Terms: = Kidney tumors AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
222 results:
1. The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
Sato H; Ito T; Hayashi T; Kitano S; Erdjument-Bromage H; Bott MJ; Toyooka S; Zauderer M; Ladanyi M
Oncogene; 2024 Apr; 43(15):1087-1097. PubMed ID: 38383726
[TBL] [Abstract] [Full Text] [Related]
2. Predictive and prognostic biomarkers in urological tumours.
Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
[TBL] [Abstract] [Full Text] [Related]
3. Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.
Takeda K; Bastacky S; Dhir R; Mohebnasab M; Quiroga-Garza GM
Ann Diagn Pathol; 2024 Feb; 68():152223. PubMed ID: 37976977
[TBL] [Abstract] [Full Text] [Related]
4. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
5. Ocular metastasis from renal malignancies - A comprehensive review.
Jindal A; Kapatia G; Gupta G
Indian J Ophthalmol; 2023 Oct; 71(10):3281-3289. PubMed ID: 37787223
[TBL] [Abstract] [Full Text] [Related]
6. Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer.
Turchiano A; Piglionica M; Martino S; Bagnulo R; Garganese A; De Luisi A; Chirulli S; Iacoviello M; Stasi M; Tabaku O; Meneleo E; Capurso M; Crocetta S; Lattarulo S; Krylovska Y; Lastella P; Forleo C; Stella A; Bukvic N; Simone C; Resta N
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628581
[TBL] [Abstract] [Full Text] [Related]
7. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
[TBL] [Abstract] [Full Text] [Related]
8. An analysis of iris pattern as a risk factor for skin cancer development in immunosuppressed renal transplant recipients.
Leahy M; Griffin L; Prendergast G; Griffin M; Laing M
J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):311-314. PubMed ID: 37590547
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic viral integration patterns actively participate in the progression of BK polyomavirus-associated diseases after renal transplantation.
Wang Y; Yan S; Liu Y; Yan Z; Deng W; Geng J; Li Z; Xia R; Zeng W; Zhao T; Fang Y; Liu N; Yang L; Cheng Z; Xu J; Wu CL; Miao Y
Am J Transplant; 2023 Nov; 23(11):1694-1708. PubMed ID: 37507072
[TBL] [Abstract] [Full Text] [Related]
10. Does Utilizing iris, a Segmented Three-dimensional Model, Increase Surgical Precision During Robotic Partial Nephrectomy?
Iarajuli T; Caviasco C; Corse T; Kim K; Nguyen J; De La Rosa RS; Gelman S; Spagnuolo N; Sidoti H; Miller M; Stifelman M
J Urol; 2023 Jul; 210(1):171-178. PubMed ID: 37027312
[TBL] [Abstract] [Full Text] [Related]
11. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Rodler E; Sharma P; Barlow WE; Gralow JR; Puhalla SL; Anders CK; Goldstein L; Tripathy D; Brown-Glaberman UA; Huynh TT; Szyarto CS; Godwin AK; Pathak HB; Swisher EM; Radke MR; Timms KM; Lew DL; Miao J; Pusztai L; Hayes DF; Hortobagyi GN
Lancet Oncol; 2023 Feb; 24(2):162-174. PubMed ID: 36623515
[TBL] [Abstract] [Full Text] [Related]
12. Treatment Strategies for Hereditary kidney Cancer: Current Recommendations and Updates.
Singh S; Chaurasia A; Gopal N; Malayeri A; Ball MW
Discov Med; 2022; 34(173):205-220. PubMed ID: 36602871
[TBL] [Abstract] [Full Text] [Related]
13. Semantic Computed Tomography Features for Predicting brca1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma.
Wu XH; Zhu JM; Lin BH; Qiu QR; Ruan ZT; Wei Y; Xue XY; Zheng QS; Chen SH; Xu N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):666-675. PubMed ID: 36586494
[TBL] [Abstract] [Full Text] [Related]
14. The BRCAness Landscape of Cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
15. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract] [Full Text] [Related]
16. Pediatric Small Renal Masses: Can Tumor Size Predict Histology and the Potential for Nephron-sparing Surgery?
Han DS; Walker JP; Nicklawsky A; Boxley P; Halstead NV; Tonzi M; Hecht SL; Staley A; Eguchi M; Cockburn MG; Roach JP; Saltzman AF; Cost NG
J Urol; 2023 Mar; 209(3):582-590. PubMed ID: 36445021
[TBL] [Abstract] [Full Text] [Related]
17. Roles of DNA damage repair and precise targeted therapy in renal cancer (Review).
Lai Y; Li Z; Lu Z; Zheng H; Chen C; Liu C; Yang Y; Tang F; He Z
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36263616
[TBL] [Abstract] [Full Text] [Related]
18. PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma.
Walton J; Lawson K; Prinos P; Finelli A; Arrowsmith C; Ailles L
Nat Rev Urol; 2023 Feb; 20(2):96-115. PubMed ID: 36253570
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
Sekine Y; Iwasaki Y; Hakozaki N; Endo M; Kamatani Y; Matsuda K; Murakami Y; Sano T; Akamatsu S; Kobayashi T; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
Jpn J Clin Oncol; 2022 Dec; 52(12):1441-1445. PubMed ID: 36093724
[TBL] [Abstract] [Full Text] [Related]
20. BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.
Langbein LE; El Hajjar R; He S; Sementino E; Zhong Z; Jiang W; Leiby BE; Li L; Uzzo RG; Testa JR; Yang H
Cancer Lett; 2022 Oct; 547():215885. PubMed ID: 35995140
[TBL] [Abstract] [Full Text] [Related]
[Next]
